BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30656676)

  • 1. Soluble CD93 is an apoptotic cell opsonin recognized by α
    Blackburn JWD; Lau DHC; Liu EY; Ellins J; Vrieze AM; Pawlak EN; Dikeakos JD; Heit B
    Eur J Immunol; 2019 Apr; 49(4):600-610. PubMed ID: 30656676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and characterization of soluble CD93 released during inflammation.
    Greenlee MC; Sullivan SA; Bohlson SS
    Inflamm Res; 2009 Dec; 58(12):909-19. PubMed ID: 19603257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
    Norsworthy PJ; Fossati-Jimack L; Cortes-Hernandez J; Taylor PR; Bygrave AE; Thompson RD; Nourshargh S; Walport MJ; Botto M
    J Immunol; 2004 Mar; 172(6):3406-14. PubMed ID: 15004139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma.
    Bohlson SS; Silva R; Fonseca MI; Tenner AJ
    J Immunol; 2005 Jul; 175(2):1239-47. PubMed ID: 16002728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD93 in allergic asthma.
    Park HJ; Oh EY; Han HJ; Park KH; Jeong KY; Park JW; Lee JH
    Sci Rep; 2020 Jan; 10(1):323. PubMed ID: 31941986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulated interaction of the ERM protein, moesin, with CD93.
    Zhang M; Bohlson SS; Dy M; Tenner AJ
    Immunology; 2005 May; 115(1):63-73. PubMed ID: 15819698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances.
    Ikewaki N; Tamauchi H; Inoko H
    Microbiol Immunol; 2007; 51(12):1189-200. PubMed ID: 18094537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD93 induces differentiation of monocytes and enhances TLR responses.
    Jeon JW; Jung JG; Shin EC; Choi HI; Kim HY; Cho ML; Kim SW; Jang YS; Sohn MH; Moon JH; Cho YH; Hoe KL; Seo YS; Park YW
    J Immunol; 2010 Oct; 185(8):4921-7. PubMed ID: 20861352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD93 Is Involved in Metabolic Dysregulation but Does Not Influence Carotid Intima-Media Thickness.
    Strawbridge RJ; Hilding A; Silveira A; Österholm C; Sennblad B; McLeod O; Tsikrika P; Foroogh F; Tremoli E; Baldassarre D; Veglia F; Rauramaa R; Smit AJ; Giral P; Kurl S; Mannarino E; Grossi E; Syvänen AC; Humphries SE; de Faire U; Östenson CG; Maegdefessel L; Hamsten A; Bäcklund A;
    Diabetes; 2016 Oct; 65(10):2888-99. PubMed ID: 27659228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis.
    Greenlee-Wacker MC; Briseño C; Galvan M; Moriel G; Velázquez P; Bohlson SS
    J Immunol; 2011 Sep; 187(6):3353-61. PubMed ID: 21849679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented production of soluble CD93 in patients with systemic sclerosis and clinical association with severity of skin sclerosis.
    Yanaba K; Asano Y; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2012 Sep; 167(3):542-7. PubMed ID: 22540233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.
    Nativel B; Ramin-Mangata S; Mevizou R; Figuester A; Andries J; Iwema T; Ikewaki N; Gasque P; Viranaïcken W
    Immunology; 2019 Oct; 158(2):85-93. PubMed ID: 31335975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD93 interacts with the PDZ domain-containing adaptor protein GIPC: implications in the modulation of phagocytosis.
    Bohlson SS; Zhang M; Ortiz CE; Tenner AJ
    J Leukoc Biol; 2005 Jan; 77(1):80-9. PubMed ID: 15459234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of serum soluble CD93 as a biomarker for asthma in an ovalbumin-induced asthma murine model.
    Park HJ; Oh EY; Park YH; Yang M; Park KH; Park JW; Lee JH
    Biomarkers; 2018 Jul; 23(5):446-452. PubMed ID: 29498549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble expression of disulfide-bonded C-type lectin like domain of human CD93 in the cytoplasm of Escherichia coli.
    Nativel B; Figuester A; Andries J; Planesse C; Couprie J; Gasque P; Viranaicken W; Iwema T
    J Immunol Methods; 2016 Dec; 439():67-73. PubMed ID: 27742562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD93 lectin-like domain sequesters HMGB1 to ameliorate inflammatory diseases.
    Huang SE; Kuo CH; Shiao SY; Shen CR; Lee FT; Chang BI; Hsu JH; Wu HL; Yeh JL; Lai CH
    Theranostics; 2023; 13(12):4059-4078. PubMed ID: 37554277
    [No Abstract]   [Full Text] [Related]  

  • 17. The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells.
    Akakura S; Singh S; Spataro M; Akakura R; Kim JI; Albert ML; Birge RB
    Exp Cell Res; 2004 Jan; 292(2):403-16. PubMed ID: 14697347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD93 in Serum as a Marker of Allergic Inflammation.
    Park HJ; Han H; Lee SC; Son YW; Sim DW; Park KH; Park YH; Jeong KY; Park JW; Lee JH
    Yonsei Med J; 2017 May; 58(3):598-603. PubMed ID: 28332366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration adhesion and migration.
    Galvagni F; Nardi F; Maida M; Bernardini G; Vannuccini S; Petraglia F; Santucci A; Orlandini M
    Oncotarget; 2016 Mar; 7(9):10090-103. PubMed ID: 26848865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variance and plasma concentration of CD93 is associated with cardiovascular mortality: Results from a 6.7‑year follow‑up of a healthy community‑living elderly population.
    Alehagen U; Shamoun L; Wågsäter D
    Mol Med Rep; 2020 Dec; 22(6):4629-4636. PubMed ID: 33173973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.